**Author details**

Stavros J. Baloyannis1,2

1 Laboratory of Neuropathology and Electron Microscopy, Department of Neurology, Aristotelian University of Thessaloniki, Greece

2 Institute for Research on Alzheimer's Disease, Iraklion, Greece

\*Address all correspondence to: sibh844@otenet.gr

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**51**

*Mitochondria and Alzheimer's Disease: An Electron Microscopy Study*

[10] Selkoe DJ. Alzheimer's disease is a synaptic failure. Science.

[11] Poirel O, Mella S, Videau C, Ramet L, Davoli MA, Herzog E, et al. Moderate decline in select synaptic markers in the prefrontal cortex (BA9) of patients with Alzheimer's disease at various cognitive stages. Scientific Reports. 2018;**8**:938

[12] Baloyannis SJ, Costa V, Michmizos D. Mitochondrial alterations in Alzheimer's disease. American Journal of Alzheimer's Disease and Other

Dementias. 2004;**19**:89-93

Diseases. 2016;**2**:004

Research. 2010;**7**:656-664

Sciences. 2012;**322**:117-121

Neurology. 1997;**56**:321-339

2005;**115**:1121-1129

2004;**430**:631-639

[13] Baloyannis SJ. Mitochondria: Strategic point in the field of Alzheimer's disease. Journal of Alzheimers and Neurodegenerative

[14] Iqbal K, Liu F, Gong CX, Grundke-Iqbal I. Tau in Alzheimer disease and related tauopathies. Current Alzheimer

[15] Mattson MP. Pathways towards and away from Alzheimer's disease. Nature.

[16] Baloyannis SJ, Baloyannis IS. The vascular factor in Alzheimer's disease: A study in Golgi technique and electron microscopy. Journal of the Neurological

[17] Dickson DM. The pathogenesis of senile plaques. Journal of Neuropathology and Experimental

[18] Gandy S. The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. The Journal of Clinical Investigation.

[19] Baloyannis S. The Golgi apparatus of Purkinje cells in Alzheimer's disease.

2002;**298**:789-791

*DOI: http://dx.doi.org/10.5772/intechopen.84881*

[1] Reitz C, Mayeux R. Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers.

Biochemical Pharmacology.

[2] Cummings JL, Morstorf T, Zhong K. Alzheimer's disease drugdevelopment pipeline: Few candidates, frequent failures. Alzheimer's Research

[3] Schelke MW, Attia P, Palenchar D, Kaplan B, Mureb M, Ganzer CA, et al. Mechanisms of risk reduction in the clinical practice of Alzheimer's disease prevention. Frontiers in Aging

[4] Baloyannis SJ. Neuropathology of Dementia. Aristotelian University of

[5] Alzheimer's Association. Alzheimer's disease facts and figures. Alzheimer's &

[6] Wisniewski HM, Wegiel J, Kotula L. Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines. Neuropathology and Applied Neurobiology. 1996;**22**:3-11

[8] Baloyannis S, Costa V, Arnaoutoglou A, Arnaoutoglou H. Synaptic alterations in the molecular layer of the cerebellum in Alzheimer's disease. Neuropathology

**References**

2014;**88**:640-651

& Therapy. 2014;**6**:37

Neuroscience. 2018;**10**:96

Dementia. 2010;**6**:158-194

[7] Duyckaerts C, Delatour B, Potier MC. Classification and basic pathology of Alzheimer disease. Acta Neuropathologica. 2009;**118**:5-36

and Applied Neurobiology.

[9] Baloyannis SJ, Manolidis SL, Manolidis LS. Synaptic alterations in the vestibule-cerebellar system in Alzheimer's disease-a Golgi and electron microscope study. Acta Oto-Laryngologica. 2000;**120**:247-250

1996;**22**:78-79

Thessaloniki; 1993

*Mitochondria and Alzheimer's Disease: An Electron Microscopy Study DOI: http://dx.doi.org/10.5772/intechopen.84881*
